Microbial models of mammalian metabolism: biotransformations of phenacetin and its O-alkyl homologues with Cunninghamella species

References

• Abel J. A. Analgesic nephropathy: a review of the literature, 1967–1970. Clinical Pharmacology and Therapeutics 1971; 12: 583–598
   PubMedGoogle Scholar
• Beutler E. Drug-induced hemolytic anemia. Pharmacological Review 1969; 21: 73–103
   PubMed Web of Science ®Google Scholar
• Boyd E. M., Bereczky G. M. Liver necrosis from phenobarbital. British Journal of Pharmacology 1966; 26: 606–614
   PubMed Web of Science ®Google Scholar
• Buhler M., Schindler J. Aliphatic hydrocarbons. Biotechnology: A Comprehensive Treatise in 8 Volumes, H. J. Rehm, G. Reed. Verlag Chemie, Weinheim 1984; Vol. 6a: 329–385, chapter 9
   Google Scholar
• Calder I. C., Goss D. E., Williams R. J., Funder C. C., Green C. R., Ham K. N., Tange J. D. Neoplasia in the rat induced by N-hydroxyphenacetin, a metabolite of phenacetin. Pathology 1976; 8: 1–7
   PubMed Web of Science ®Google Scholar
• Carro-Ciampi G. Phenacetin abuse: a review. Toxicology 1978; 10: 311–339
   PubMed Web of Science ®Google Scholar
• Cerniglia C. E. Microbial metabolism of polycyclic aromatic hydrocarbons. Advances in Applied Microbiology 1984; 30: 31–71
   PubMed Web of Science ®Google Scholar
• Clark A. M., McChesney J. D., Hufford C. D. The use of microorganisms for the study of drug metabolism. Medicinal Research Reviews 1985; 5: 231–253
   PubMed Web of Science ®Google Scholar
• Coutts R. T., Foster B. C., Grahm R. J., Meyers G. E. Metabolism of N-(n-propyl)amphetamine by Cunninghamella echinulata. Applied Environmental Microbiology 1979; 37: 429–432
   PubMed Web of Science ®Google Scholar
• Coutts R. T., Foster B. C., Posutto F. M. Fungal metabolism of (-)-deprenyl and pargyline. Life Sciences 1981; 29: 1951–58
   PubMedGoogle Scholar
• Davidson D. G. D., Eastham W. N. Acute liver necrosis following overdose of paracetamol. British Medical Journal 1966; 2: 497–99
   PubMed Web of Science ®Google Scholar
• Davis P. J. Developments in Industrial Microbiology 1988; 29: 197–219
   Google Scholar
• Ferris M. J., Fasco M. J., Stylianopoulou F. L., Jerina D. M., Daly J. W., Jeffrey A. M. Monooxygenase activity in Cunninghamella bainieri: evidence for a fungal system similar to liver microsomes. Archives of Biochemistry and Biophysics 1973; 156: 97–103
   PubMed Web of Science ®Google Scholar
• Foster B. C., Coutts R. T., Pasutto F. M. Biotransformation of arylalkylamines by Cunninghamella bainieri. Xenobiotica 1989; 19: 531–38
   PubMed Web of Science ®Google Scholar
• Hansen E. B., Cerniglia C. E., Korfmacher W. A., Miller D. W., Heflich R. F. Microbial transformation of the antihistamine pyrilamine maleate: formation of potential mammalian metabolites. Drug Metabolism and Disposition 1987; 15: 97–106
   PubMed Web of Science ®Google Scholar
• Hinson J. A. Reactive metabolites of phenacetin and acetaminophen: a review. Environmental Health Perspective 1983; 49: 71–79
   PubMed Web of Science ®Google Scholar
• Hinson J. A., Nelson S. D., Gillette J. R. Studies on the activation of p-18O-phenacetin to a reactive metabolite in hamsters. Federation Proceedings 1978; 37: 644
   Google Scholar
• Hinson J. A., Nelson S. D., Gillette J. R. Metabolism of [p-18O-phenacetin: the mechanism of activation of phenacetin to reactive metabolites in hamsters. Molecular Pharmacology 1979; 15: 419–427
   PubMed Web of Science ®Google Scholar
• Iishi H., Hayashi M., Niwaguchi T., Nakahara Y. Studies on lysergic acid diethylamide. IX. Microbial transformations of amides related to lysergic acid diethylamide by Streptomyces roseochromogenes. Chemical and Pharmaceutical Bulletin 1979; 27: 3029–3034
   Google Scholar
• Jollow D. J., Mitchell J. R., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. Journal of Pharmacology and Experimental Therapeutics 1973; 187: 195–202
   PubMed Web of Science ®Google Scholar
• Kapetanovic I. M., Strong J. M., Mieyal J. J. Metabolic structure-activity relationships for a homologous series of phenacetin analogs. Journal of Pharmacology and Experimental Therapeutics 1979; 209: 20–24
   PubMed Web of Science ®Google Scholar
• Kergomard A. Alicyclic and heterocyclic compounds. Biotechnology: A Comprehensive Treatise in 8 Volumes, H. J. Rehm, G. Reed. Verlag Chemie, Weinheim 1984; Vol. 6a: 127–205, chapter 5
   Google Scholar
• Lasswell W. L., Bob J., Young K. A. An undergraduate experiment in pharmacognosy: the microbial biotransformation of acetanilid by Aspergillus species. Journal of Pharmaceutical Education 1983; 47: 127–129
   Google Scholar
• Mihatsch M. J., Knusli C. Phenacetin abuse and malignant tumors: an autopsy study covering 25 years (1953-1977). Klinisch Wochenschrift 1982; 60: 1339–1349
   PubMedGoogle Scholar
• Mitchell J. R., Jallow D. J., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. Journal of Pharmacology and Experimental Therapeutics 1973; 187: 185–94
   PubMed Web of Science ®Google Scholar
• Mitchell J. R., Jollow D. J., Potter W. Z., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. Journal of Pharmacology and Experimental Therapeutics 1973; 187: 211–217
   PubMed Web of Science ®Google Scholar
• Monks T. J., Lau S. S. Reactive intermediates and their toxicological significance. Toxicology 1988; 52: 1–53
   PubMed Web of Science ®Google Scholar
• Nelson S. D., Forte A. J., Vaisnav Y., Mitchell J. R., Gillette J. R., Hinson J. A. The formation of arylating and alkylating metabolites of phenacetin in hamsters and hamster liver microsomes. Molecular Pharmacology 1981; 19: 140–145
   PubMed Web of Science ®Google Scholar
• Potter W. Z., Davis D. C., Mitchell J. R., Jollow D. J., Gillette J. R., Brodie B. B. Actaminophen-induced hepatic necrosis. III. Cytochrome P-450 mediated covalent. Journal of Pharmacology and Experimental Therapeutics 1973; 187: 203–210
   PubMed Web of Science ®Google Scholar
• Rizzo J. D., Davis P. J. Microbial models of mammalian metabolism: conversion of warfarin to 4′-hydroxywarfarin using Cunninghamella bainieri (UI-3065). Journal of Pharmaceutical Science 1989; 78: 183–189
   PubMedGoogle Scholar
• Robertson L. W. Microbial transformation of cannabinoid. Microbial Transformations of Bioactive Compounds, J. P. Rosazza. CRC Press, Boca Raton, FL 1982; Vol. 2: 91–123, chapter 4
   Google Scholar
• Smith R. V., Milton S. A. G., Davis P. J. Microbial models of mammalian metabolism. O-Dealkylation of para-alkoxybiphenyls. Applied and Environmental Microbiology 1982; 4: 149–52
   Google Scholar
• Smith R. V., Rosazzo J. P. Microbial models of mammalian metabolism. Journal of Pharmaceutical Science 1975; 64: 1737–1759
   PubMed Web of Science ®Google Scholar
• Smith R. V., Rosazzo J. P. Microbial models of mammalian metabolism. Journal of Natural Products 1983; 46: 79–91
   PubMed Web of Science ®Google Scholar
• VanBree L., Redegeld F. A. M., De Vries J. The 3-methylcholantrene-mimetic effect of 4,4-dichlorobiphenyl-treatment on phenacetin-induced hepatic glutathione depletion and liver microsomal phenacetin O-deethylation in rats. Toxicology 1986; 42: 259–74
   PubMedGoogle Scholar
• Veronese M. E., McLean S., D'Souza C. A., Davies N. W. Formation of reactive metabolites of phenacetin in humans and rats. Xenobiotica 1985; 15: 929–940
   PubMed Web of Science ®Google Scholar
• Williams D. A. Drug metabolism. Principles of Medicinal Chemistry 3rd edn, W. O. Foye. Lea and Febiger, Philadelphia, PA 1988; 79–118, chapter 5
   Google Scholar
• Wirth P. J., Dybing E., von Bahr C., Thorgeirsson S. S. Mechanism of N-hydroxyacetylarylamine mutagenicity and the Salmonella test system: metabolic activation of N-hydroxyphenacetin by liver and kidney fractions from rat, mouse, hamster, and man. Molecular Pharmacology 1980; 18: 117–127
   PubMed Web of Science ®Google Scholar
• Wong W. J., Davis P. J. Microbial models of mammalian metabolism. Stereoselective metabolism of warfarin by the fungus. Cunninghamellaelegans. Pharmaceutical Research 1989; 6: 982–97
   PubMedGoogle Scholar